Roles of Physicians, Scientists and Engineers in High-tech Startups

March 19 – April 24, 2018 • Tuesdays and Thursdays, 5 PM – 7 PM (EST)
(NOTE: Only the first class is on a Monday)
Charles T. Wethington, Jr. Building, Room 312
University of Kentucky, Corner of Rose St and South Lime

Sponsored by UKHealthcare, Gill Heart Institute, Center for Clinical Translational Science (CCTS) and the College of Engineering.
Sponsored by UKHealthcare, Gill Heart Institute, Center for Clinical Translational Science (CCTS) and the College of Engineering.

The roles of physicians, scientists, engineers and MBAs in biotech, medical device, and other life science companies will be described and characterized.  The major trends and innovations driving the creation of new products in large, established companies and venture-capital-backed startup companies are discussed.  This pragmatic, experienced-based course describes the venture capital process, the formation and capitalization of high-tech companies, sources of technologies, role of tech transfer at universities and medical schools, startup operational issues, role of VCs and board members, execution time frames, the liquidity process, IPOs and mergers, and payout prospects for founders and investors.

Live, ongoing case studies guest entrepreneurs: biotech, medical device and healthcare informatics companies are presented by many notable M.D. and Ph.D. founders and CEOs. In the final classes, a high-tech career-planning guide is discussed, plus a special lecture on Intelligence, Leadership and Entrepreneurship will be presented.  Insider secrets and success stories from decades of highly successful company formations and Venture Capital practice in medical, biotech and infotech companies will be shared.

Sponsored by UKHealthcare, Gill Heart Institute, Center for Clinical Translational Science (CCTS) and the College of Engineering.

Course Faculty:        
Jack M. Gill, PhD
Paul Cherukuri, PhD

Adrian Trömel,
Norah Owiti,

Course Registration: Here
Free – No charge – Attend any/all lectures
Questions: Contact Tony Elam –

Class Schedule

Monday, March 19    (NOTE: this is the only class session held on a Monday)
Course Intro, Schedule, Grading, Homework
Entrepreneurs, VCs & VC Firms, Vanguard Story

Tuesday, March 20  
Startup Company Dynamics
Guest:  Mehdi Razavi, MD

Thursday, March 22
Biotech, Diagnostics, Devices, and Pharmaceutical Industries
Guest:  William Cohn, MD

Tuesday, March 27  
Startup Financings, Valuations, Outcomes
Guest:  Jean van Soelen, MBA

Thursday, March 29 
Intelligence, Leadership and Entrepreneurship
Guest:  Larry Lawson

Tuesday, April 3   
Stock Options & Compensation and Role of Boards in Startups
Guest:  John Cooke, MD, PhD

Thursday April 5        
Guest:  Brittany Barreto, PhD
Guest:  Bryan Haardt
Mid-semester Quiz

Tuesday, April 10  
Entrepreneur Support Organizations
Guests:  Tom Luby, PhD, Erik Halvorsen, PhD, Brad Burke, MBA, enventure Leaders                

Thursday, April 12  
Landmines on the Road to Success
Guest:  James W. Welsh, MD
BBQ Dinner w/ Scott Parazynski, MD

Tuesday, April 17   
Twelve Life Science Case Studies
Guest:  Todd Rosengart, MD, FACS
 Student Essays Due

Thursday, April 19  
Career Planning Lecture & Student Discussion
 Guest: Alexander Schueller, MBA

Tuesday, Apr. 24   
Summary, Q&A and Course Survey; Student Presentations


Screen Shot 2018-02-09 at 11.18.53 AM copyJack Gill is a 35-year veteran of Silicon Valley and Boston and has founded and financed dozens of successful companies in the instrumentation, computer, telecom, and medical industries.  He co-founded Vanguard Ventures in 1981.  Vanguard’s first five funds invested $155 million in 103 startups which generated more than $1 billion return to investors.  Successes include Aldus, AFC, Ciena, EndoSonics, Indigo Medical, Mycogen, Digital Microwave, Tut Systems, Cobalt Networks, Digital Island, Network Appliance and Hansen Medical.  Dr. Gill joined the Harvard Medical School faculty in 2000.  He teaches entrepreneur courses at Harvard, MIT, Stanford, and Rice. Jack was on the boards of the National Academies, Project HOPE, the Horatio Alger Association and MD Anderson.  He is a former Trustee of Indiana University & member of the Executive council of the Texas ETF.  Jack was a 1999 winner of the Horatio Alger Award
E-mail: Jack M. Gill, PhD


20ccdfePaul Cherukuri earned his PhD in Chemistry under the supervision of Nobel Laureate Richard E. Smalley and R. Bruce Weisman at Rice University and has a 15+ year history in academia and industry. As Executive Director of the Institute of Biosciences and Bioengineering (IBB), Paul is responsible for the development and implementation of cross-disciplinary research and educational programs that strengthen Rice University’s scientific development in biosciences and bioengineering. He serves as the key liaison between Rice University and the Texas Medical Center to support and develop collaborative research opportunities for IBB faculty and the broader Rice science/engineering community. Paul also directs an active research program in the field of scalable directed self-assembly of artificial and biological nanoscale materials (Teslaphoresis) and is a subject matter expert in nanotechnology, drug development and biomedical devices.


Download Spring 2018 Agenda for Life Science Entrepreneurship Roles of Physicians, Scientists and Engineers in High-tech Startups